Cavitating cryptococcal pneumonia in the immunocompetent host

M S Koh1, B H Tan, A Kurup

  • 1Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Outram Road, Singapore 169608.

Abstract

Insights

Oral fluconazole effectively treats cryptococcal pneumonia in immunocompetent patients. Treatment continued until serum cryptococcal antigen (SCA) levels normalized, showing clinical, radiological, and serological improvement.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Mycology

Background:

  • Cryptococcal pneumonia is rare in immunocompetent individuals.
  • Treatment guidelines and duration are undefined for this condition.
  • Cavitating pulmonary cryptococcosis presents unique clinical challenges.

Purpose of the Study:

  • To evaluate the efficacy and safety of oral fluconazole for cryptococcal pneumonia in immunocompetent hosts.
  • To explore the role of serum cryptococcal antigen (SCA) monitoring in treatment management.

Main Methods:

  • Retrospective analysis of three immunocompetent patients with cavitating cryptococcal pneumonia.
  • Treatment with oral fluconazole.
  • Monitoring of clinical, radiological, and serological parameters, including SCA levels.

Main Results:

  • All three patients showed significant clinical, radiological, and serological improvement.
  • Fluconazole treatment was continued until negative SCA levels were achieved.
  • Manifestations like hemoptysis and cavitating pneumonia indicated potentially severe disease.

Conclusions:

  • Oral fluconazole is an effective and safe treatment option for cryptococcal pneumonia in immunocompetent hosts.
  • Monitoring SCA levels may indicate disease burden and guide treatment duration.
  • Extended treatment duration appears beneficial, outweighing potential risks.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...